ETFis Series Trust I (BBC)
Management Company · ARCX · Series S000047353 · View on SEC EDGAR ↗
- Net assets
- $37.3M
- Holdings
- 125
- As of
- April 30, 2026 stale
- Top 10 holdings weight
- 17.13%
- Effective number of positions
- 98.9
- Positions above 1%
- 27
On this page
- Fund flows Money flowing in and out of the fund each month, from N-PORT filings.
- Holdings Every position the fund currently holds, with weights.
- Sector breakdown How the fund's holdings split across market sectors.
- Institutional owners 13F institutions that report holding this ETF.
- Similar funds Other funds with overlapping holdings or comparable size.
Fund flows (SEC-reported)
- Last month (Apr 2026)
- +$175K
- Quarter ending Apr 2026
- -$1.8M
- Trailing 12 months
- +$5.5M
May 2025 – Apr 2026
Based on the fund's own SEC Form N-PORT monthly flow disclosures (Item C.9 "Flow Information") — sales minus redemptions, reinvested distributions excluded. This is a different, independent metric from the "Net flows" estimate above (which is derived from daily shares-outstanding changes). SEC N-PORT filing lag is up to ~60 days; the most recent month/quarter may not yet be fully reflected.
Full composition 125 holdings
| Name | CUSIP | Value | % | Balance | Category | Country |
|---|---|---|---|---|---|---|
| PRECIGEN INC | 74017N105 | $311K | 0.83 | 74,799 | EC | US |
| BELITE BIO INC | 07782B104 | $311K | 0.83 | 1,952 | EC | KY |
| BEAM THERAPEUTICS INC | 07373V105 | $306K | 0.82 | 10,087 | EC | US |
| MOONLAKE IMMUNOTHERAPEUTICS | 61559X104 | $306K | 0.82 | 18,661 | EC | KY |
| TAYSHA GENE THERAPIES INC | 877619106 | $305K | 0.82 | 47,669 | EC | US |
| CULLINAN THERAPEUTICS INC | 230031106 | $302K | 0.81 | 23,153 | EC | US |
| IMMATICS NV | — | $302K | 0.81 | 27,490 | EC | NL |
| RAPPORT THERAPEUTICS INC | 75383L102 | $302K | 0.81 | 9,118 | EC | US |
| ZYMEWORKS INC | 98985Y108 | $298K | 0.80 | 10,832 | EC | US |
| APOGEE THERAPEUTICS INC | 03770N101 | $297K | 0.79 | 3,580 | EC | US |
| PROTHENA CORP PLC | — | $295K | 0.79 | 26,642 | EC | IE |
| ORIC PHARMACEUTICALS INC | 68622P109 | $291K | 0.78 | 29,424 | EC | US |
| DENALI THERAPEUTICS INC | 24823R105 | $287K | 0.77 | 15,351 | EC | US |
| PROTAGONIST THERAPEUTICS INC | 74366E102 | $286K | 0.77 | 2,894 | EC | US |
| MEIRAGTX HOLDINGS PLC | — | $285K | 0.76 | 30,942 | EC | KY |
| IMMUNOVANT INC | 45258J102 | $284K | 0.76 | 10,446 | EC | US |
| ROCKET PHARMACEUTICALS INC | 77313F106 | $283K | 0.76 | 81,418 | EC | US |
| UNIQURE NV | — | $282K | 0.76 | 14,147 | EC | NL |
| SOLENO THERAPEUTICS INC | 834203309 | $280K | 0.75 | 5,306 | EC | US |
| MBX BIOSCIENCES INC | 55287L101 | $279K | 0.75 | 9,242 | EC | US |
| STOKE THERAPEUTICS INC | 86150R107 | $279K | 0.75 | 8,521 | EC | US |
| CYTOKINETICS INC | 23282W605 | $279K | 0.75 | 4,355 | EC | US |
| CYTOMX THERAPEUTICS INC | 23284F105 | $278K | 0.74 | 65,872 | EC | US |
| SCHOLAR ROCK HOLDING CORP | 80706P103 | $274K | 0.74 | 5,888 | EC | US |
| ATAIBECKLEY INC | 04650F101 | $268K | 0.72 | 64,337 | EC | US |
| NUVALENT INC | 670703107 | $264K | 0.71 | 2,633 | EC | US |
| JANUX THERAPEUTICS INC | 47103J105 | $259K | 0.69 | 18,038 | EC | US |
| SEPTERNA INC | 81734D104 | $258K | 0.69 | 10,849 | EC | US |
| DYNE THERAPEUTICS INC | 26818M108 | $251K | 0.67 | 14,322 | EC | US |
| SIONNA THERAPEUTICS INC | 829401108 | $250K | 0.67 | 6,453 | EC | US |
| KYMERA THERAPEUTICS INC | 501575104 | $249K | 0.67 | 3,077 | EC | US |
| ARBUTUS BIOPHARMA CORP | 03879J100 | $246K | 0.66 | 58,600 | EC | CA |
| NURIX THERAPEUTICS INC | 67080M103 | $242K | 0.65 | 14,473 | EC | US |
| PRIME MEDICINE INC | 74168J101 | $239K | 0.64 | 67,319 | EC | US |
| PROKIDNEY CORP | 74291D104 | $237K | 0.64 | 124,892 | EC | US |
| ENGENE THERAPEUTICS INC | 29286X101 | $237K | 0.64 | 32,625 | EC | CA |
| IDEAYA BIOSCIENCES INC | 45166A102 | $236K | 0.63 | 8,112 | EC | US |
| XERIS BIOPHARMA HOLDINGS INC | 98422E103 | $236K | 0.63 | 38,494 | EC | US |
| COGENT BIOSCIENCES INC | 19240Q201 | $235K | 0.63 | 6,554 | EC | US |
| VIKING THERAPEUTICS INC | 92686J106 | $232K | 0.62 | 7,443 | EC | US |
| BIOHAVEN LTD | — | $230K | 0.61 | 23,938 | EC | VG |
| EYEPOINT INC | 30233G209 | $228K | 0.61 | 17,260 | EC | US |
| 4D MOLECULAR THERAPEUTICS INC | 35104E100 | $226K | 0.60 | 25,461 | EC | US |
| RECURSION PHARMACEUTICALS INC | 75629V104 | $221K | 0.59 | 63,742 | EC | US |
| ARVINAS INC | 04335A105 | $217K | 0.58 | 21,940 | EC | US |
| NEWAMSTERDAM PHARMA COMPANY NV | — | $212K | 0.57 | 7,408 | EC | NL |
| SAVARA INC | 805111101 | $209K | 0.56 | 39,885 | EC | US |
| ASSEMBLY BIOSCIENCES INC | 045396207 | $206K | 0.55 | 7,645 | EC | US |
| XENCOR INC | 98401F105 | $199K | 0.53 | 16,707 | EC | US |
| MINERALYS THERAPEUTICS INC | 603170101 | $199K | 0.53 | 7,478 | EC | US |
Page 2
of 3
Sector breakdown
Healthcare
88.9%
Other/Unmapped
11.1%
Institutional owners (13F) 20 filers
Institutions that report holding this ETF in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| Institution | Value | % of tracked 13F | Shares | Type | As of |
|---|---|---|---|---|---|
| Kera Capital Partners, Inc. | $5,321,454 | 25.26% | 101,003 | Shares | June 30, 2026 |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $3,643,703 | 17.30% | 68,536 | Shares | June 30, 2026 |
| Militia Capital Management LLC | $2,405,805 | 11.42% | 45,663 | Shares | June 30, 2026 |
| CITADEL ADVISORS LLC | $2,251,593 | 10.69% | 42,736 | Shares | June 30, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2,052,650 | 9.75% | 38,960 | Shares | June 30, 2026 |
| Quantinno Capital Management LP | $1,212,254 | 5.76% | 23,009 | Shares | June 30, 2026 |
| Militia Capital Partners, LP | $1,205,501 | 5.72% | 31,263 | Shares | Dec. 31, 2025 |
| MORGAN STANLEY | $791,609 | 3.76% | 15,025 | Shares | June 30, 2026 |
| LPL Financial LLC | $649,567 | 3.08% | 12,329 | Shares | June 30, 2026 |
| GOLDMAN SACHS GROUP INC | $456,999 | 2.17% | 8,674 | Shares | June 30, 2026 |
| ENVESTNET ASSET MANAGEMENT INC | $234,348 | 1.11% | 4,448 | Shares | June 30, 2026 |
| OSAIC HOLDINGS, INC. | $221,610 | 1.05% | 4,206 | Shares | June 30, 2026 |
| Worth Asset Management, LLC | $215,644 | 1.02% | 4,093 | Shares | June 30, 2026 |
| Operose Advisors LLC | $119,808 | 0.57% | 2,274 | Shares | June 30, 2026 |
| UBS Group AG | $110,430 | 0.52% | 2,096 | Shares | June 30, 2026 |
| Institute for Wealth Management, LLC. | $99,577 | 0.47% | 1,890 | Shares | June 30, 2026 |
| Dynamic Wealth Strategies, LLC | $48,840 | 0.23% | 927 | Shares | June 30, 2026 |
| GROUP ONE TRADING LLC | $15,806 | 0.08% | 300 | Shares | June 30, 2026 |
| Federation des caisses Desjardins du Quebec | $5,795 | 0.03% | 110 | Shares | June 30, 2026 |
| Allworth Financial LP | $527 | 0.00% | 10 | Shares | June 30, 2026 |
Peer funds
Similar by size
| Fund | AUM |
|---|---|
| FMNY First Trust Exchange-Traded Fun… | $37.4M |
| TYD Direxion Shares ETF Trust | $37.6M |
| RSSE First Trust Exchange-Traded Fun… | $37.6M |
| OVM Listed Funds Trust | $38.0M |
| ASHS DBX ETF Trust | $38.3M |
| GRZZ Tidal Trust II | $37.2M |
| GFGF EA Series Trust | $37.1M |
| NRES DBX ETF Trust | $37.0M |
| FTBD Fidelity Merrimack Street Trust | $36.9M |
| XISE First Trust Exchange-Traded Fun… | $36.6M |